Profound Medical (PROF) Cash from Operations Growth (1y) (2025 - 2026)

Profound Medical (PROF) Cash from Operations Growth (1y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Ops. Growth (1y) (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	21.54%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	13.50%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	1.78%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	14.62%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	124.64%
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-11.16%
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	78.72%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-0.23%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	-12.60%
10	Profound Medical	247.18 Mn	208.91 Mn	1.95 Mn	17.51%

Download Data